Elahere 72903-0853-01

Generic: Mirvetuximab Soravtansine

Package NDC

72903-0853-01

Manufacturer: Immunogen, Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: November 14, 2022
Listing Expires: December 31, 2027
Application: BLA761310

Need to source Elahere? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Mirvetuximab Soravtansine	5 mg/mL

Selected Package

72903-0853-01Selected

1 VIAL, SINGLE-USE in 1 CARTON (72903-853-01) / 20 mL in 1 VIAL, SINGLE-USE